» Articles » PMID: 33572400

The Evolving Landscape of Fungal Diagnostics, Current and Emerging Microbiological Approaches

Overview
Journal J Fungi (Basel)
Date 2021 Feb 12
PMID 33572400
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Invasive fungal infections are increasingly recognized in immunocompromised hosts. Current diagnostic techniques are limited by low sensitivity and prolonged turnaround times. We review emerging diagnostic technologies and platforms for diagnosing the clinically invasive disease caused by , , and Mucorales.

Citing Articles

Retrospective analysis of 300 microbial cell-free DNA sequencing results in routine blood stream infection diagnostics.

Neidhofer C, Klein N, Yuruktumen A, Hattenhauer T, Mispelbaum R, Bode C Front Cell Infect Microbiol. 2025; 15:1504262.

PMID: 39949721 PMC: 11821936. DOI: 10.3389/fcimb.2025.1504262.


Recent Advances in Diagnostic Approaches for Mucormycosis.

Safiia J, Diaz M, Alshaker H, Atallah C, Sakr P, Moshovitis D J Fungi (Basel). 2024; 10(10).

PMID: 39452679 PMC: 11509022. DOI: 10.3390/jof10100727.


[Research advances on invasive fungal infections after burns].

Cai Y, Cheng X, Zhan J, Luo J, Liao W Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023; 39(3):269-274.

PMID: 37805724 PMC: 11630403. DOI: 10.3760/cma.j.cn501225-20220523-00199.


Fungal Infections Identified with Multiplex PCR in Severe COVID-19 Patients during Six Pandemic Waves.

Bogdan I, Reddyreddy A, Nelluri A, Maganti R, Bratosin F, Fericean R Medicina (Kaunas). 2023; 59(7).

PMID: 37512065 PMC: 10385930. DOI: 10.3390/medicina59071253.


Emerging Materials, Wearables, and Diagnostic Advancements in Therapeutic Treatment of Brain Diseases.

Ramasubramanian B, Reddy V, Chellappan V, Ramakrishna S Biosensors (Basel). 2022; 12(12).

PMID: 36551143 PMC: 9775999. DOI: 10.3390/bios12121176.


References
1.
Gunasekera M, Narine M, Ashton M, Esfandiari J . Development of a Dual Path Platform (DPP®) immunoassay for rapid detection of Candida albicans in human whole blood and serum. J Immunol Methods. 2015; 424:7-13. DOI: 10.1016/j.jim.2015.04.014. View

2.
Zaragoza R, Peman J, Quindos G, Iruretagoyena J, Cuetara M, Ramirez P . Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients. Clin Microbiol Infect. 2009; 15(6):592-5. DOI: 10.1111/j.1469-0691.2009.02794.x. View

3.
Avni T, Leibovici L, Paul M . PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol. 2010; 49(2):665-70. PMC: 3043518. DOI: 10.1128/JCM.01602-10. View

4.
Leeflang M, Debets-Ossenkopp Y, Wang J, Visser C, Scholten R, Hooft L . Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev. 2015; (12):CD007394. PMC: 6483812. DOI: 10.1002/14651858.CD007394.pub2. View

5.
Pancholi P, Carroll K, Buchan B, Chan R, Dhiman N, Ford B . Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis. J Clin Microbiol. 2018; 56(4). PMC: 5869823. DOI: 10.1128/JCM.01329-17. View